CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 80.96% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.
Open platformOpen platform

Omega Healthcare Investors Q3 AFFO rises, full-year guidance raised

By Reuters News


Overview

  • US healthcare REIT's Q3 Adjusted FFO rose yr/yr, FAD also increased

  • Company completed $1.5 bln in new investments year-to-date, including $946 mln since quarter-end

  • Omega raised full-year 2026 Adjusted FFO guidance


Outlook

  • Omega raises 2026 AFFO guidance to $3.28-$3.30 per diluted share from $3.22-$3.26

  • Company expects to make further accretive investments through year-end and into early 2027

  • Omega says operating metrics remain robust, with operator coverage improving in the quarter


Result Drivers

  • NEW INVESTMENTS - Co completed $182 mln of investments in Q3 and $946 mln since quarter-end, including acquisitions of care facilities and funding of real estate loans

  • PORTFOLIO RESTRUCTURING - Co converted two U.K. operator relationships covering 30 care homes to RIDEA structures for $48 mln and transitioned 32 Florida SNFs to a new operator, increasing annual rent

  • OPERATOR COVERAGE IMPROVEMENT - Co said operator coverage ratios and operating metrics improved in the quarter


Company press release:


Key Details

Metric

Beat/Miss

Actual

Consensus Estimate

Q3 EPS

$0.27

Q3 Net Income

$87 mln

Q3 Adjusted FFO

$262.1 mln


Analyst Coverage

  • The current average analyst rating on the shares is "hold" and the breakdown of recommendations is 8 "strong buy" or "buy", 9 "hold" and 2 "sell" or "strong sell"

  • The average consensus recommendation for the specialized reits peer group is "buy"

  • Wall Street's median 12-month price target for Omega Healthcare Investors, Inc. is $52.00, about 10.6% above its November 2 closing price of $47.00

  • The stock recently traded at 22 times the next 12-month earnings vs. a P/E of 25 three months ago


Reuters Recommended Reads

  • Nov 2 - Sabra Health Care REIT Q3 revenue rises year-over-year

  • Nov 2 - Diversified Healthcare Trust Q3 net loss narrows amid occupancy growth

  • Nov 2 - Senior housing REIT Janus Living's Q3 revenue jumps 78%, FFO up 46%


For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.


(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)

Capital.com is an execution-only brokerage platform and the content provided on the Capital.com website is intended for informational purposes only and should not be regarded as an offer to sell or a solicitation of an offer to buy the products or securities to which it applies. No representation or warranty is given as to the accuracy or completeness of the information provided.

The information provided does not constitute investment advice nor take into account the individual financial circumstances or objectives of any investor. Any information that may be provided relating to past performance is not a reliable indicator of future results or performance.

To the extent permitted by law, in no event shall Capital.com (or any affiliate or employee) have any liability for any loss arising from the use of the information provided. Any person acting on the information does so entirely at their own risk.

Any information which could be construed as “investment research” has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such is considered to be a marketing communication.